This chapter uses a series of case studies to illustrate that inconsistent research findings are all too common. The first case deals with the use of mam-mography to screen for breast cancer and how the appearance of a negative study, after a run of studies that supported the use of mammography, caused the medical community to rethink the value of mammography. Eventually after a consensus was reached that mammography could detect early cancer and save lives, doubts lingered because of the harm caused by false positive results. The second case follows the disastrous plight of the contraceptive device, Dalkon Shield. Reports claiming the Shield caused a pelvic inflammatory disease became so pervasive that the product had to be withdrawn, but the number of lawsuits drove the company into bankruptcy. However, it appears likely that its downfall may have been due to shoddy research and overzealous regulators. The final example involves aspirin use to prevent a heart attack. Using the same kind of subject (doctors) and similar designs, contrasting results between major U.S. and U.K. trials occurred. Although additional research supported the US findings of a positive effect, the FDA never approved this use of aspirin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Chapter 16 — Research Results that Clashed
Cited References
Alexander F, Anderson T, Brown H, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994:70;542–548.
Commentary. Letters to the editor. Cochrane review on screening for breast cancer with mam-mography. Lancet 2001:358;2164.
Gotzsche P, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000:355;129–134.
Kerlikowske K, Grady D, Rubin S, et al. Efficacy of screening mammography: a meta-analysis. JAMA 1995:11;149–154.
Mayor S. Swedish study questions mammography screening programmes. Br Med J 1999:318;621.
Miller A, Baines C, To T, et al. Canadian national breast screening study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992:147;1459–1476.
Nystrom L, Rutqvist L, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised studies. Lancet 1993:341;973–978.
Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002:359;909–919.
Shapiro S, Venet W, Strax P, et al. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982:69;349–355.
Burkman R. Association between intrauterine device and pelvic inflammatory disease. Obstet Gynecol 1981:57;269–276.
Christian C. Maternal deaths associated with intrauterine device. Am J Obstet Gynecol 1974:119;441–444.
Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001:357;89–95.
Farley T, Rosenberg M, Rowe P, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992:33;785–788.
Gareen I, Greenland S, Morgenstern H. Intrauterine devices and pelvic inflammatory disease meta analysis of published studies, 1974–1990. Epidemiol 2000:11;589–597.
Kromal R, Whitney C, Mumford S. The intrauterine device and pelvic inflammatory disease: the women's health study reanalyzed. J Clin Epidemiol 1991:44;109–122.
Mumford S, Kessel E. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings. Fertil Steril 1992:57;1151–1176.
Ory H. A review of the association between intrauterine devices and acute pelvic inflammatory disease. J Reprod Med 1978:20;200–204.
Boston Collaborative Drug Surveillance Program. Regular aspirin intake and acute myocardial infarction. Br Med J 1974:1;440–444.
Hammond E, Garfinkel L. Aspirin and coronary heart disease: findings of a prospective study. Br Med J 1975:2;269–271.
Hansson L, Zanchetti A, Carruthers A, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998:351;1755–1762.
Hennekens C, Karlson L, Rosner B. A case-control study of regular aspirin use and coronary deaths. Circulation 1978:58;35–38.
Jick H, Miettinen O. Regular aspirin use and myocardial infarction. Br Med J 1976:1;1057.
Paganini-Hill A, Chao A, Ross R, et al. Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 1989:299;1247–1250.
Peto R, Gray R, Collins R, et al. Randomized trial of prophylactic daily aspirin in British male doctors. Br Med J 1988:296;13–16.
Steering Committee of the Physicians' Health Study Research Group. Preliminary report: findings from the aspirin component of the ongoing Physicians' Health Study. New Engl J Med 1988:318;262–264.
Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. New Engl J Med 1989:321;129–35.
The Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998:351;233–241.
General References
Farmer C, Kane K. Screening decreases breast cancer-specific deaths but not all-cause mortality. J Fam Pract 2002:51;513.
Freedman D, Petitti D, Robins J. On the efficacy of screening for breast cancer. Int J Epidemiol 2004:33;43–55.
Goodman S. The mammography dilemma: a crisis for evidence-based medicine. Ann Intern Med 2002:137;363–365.
Gotzsche P. Mammographic screening: no reliable supporting evidence? Lancet 2002:359;706.
Gotzsche P, Olsen O. Screening mammography reevaluated. Lancet 2000:355;752.
Juffs H, Tannock I. Screening trials are even more difficult than we thought they were. J Natl Cancer Inst 2002:94;167–173.
Mocharnuk R. Mammography: the screening controversy continues. 38th Annual Meeting of the Am Soc Clin Oncol 2002 May 18–21, Orlando, FL.
Olsen O, Gotzsche P. Cochrane review on screening for breast cancer with mammography. Lancet 2001:358;1340–1342.
Woolf S. Taking critical appraisal to extremes: the need for balance in the evaluation of evidence. J Fam Pract 2000:49;1081.
Wright C, Mueller C. Screening mammography and public health policy: the need for perspective. Lancet 1995:346;29–32.
Barron T. IUDs struggle to shake off legacy of past. Family Plan World 1992:2;10–11.
Burkman R, Lee N, Ory H, et al. Response to “The intrauterine device and pelvic inflammatory disease: the Women's Health Study reanalyzed.” J Clin Epidemiol 1991:44;123–125.
Cheng D. Intrauterine device: still misunderstood after all these years. South Med J 2000:93;859–864.
Goodhue P. The Dalkon Shield debate. Conn Med 1983:47;138–141.
Women's Resource Health Center. What was the Dalkon Shield? http://health.yahoo.com/birth control-overview/what-was-the-dalkon-shield/pdr--Women_wmn_art_00018535.html Jan 1, 2003.
Agency for Healthcare Research and Quality. U.S. Preventive Services Task Force urges clinicians and patients to discuss aspirin therapy. http://72.14.205.104/search?q=cache:JVcNc OfrpMUJ:www.ahrq.gov/news/press/pr2002/aspirpr.htm + U.S. + Preventive + Services + Task + force + aspirin + use + heart + attack&hl=en&ct=clnk&cd=1&gl=us Jan 14, 2002.
Altman L. New questions on aspirin and heart; two studies produce seemingly contrasting results. New York Times Nov 18, 1989:8.
Hennekens C. Update on aspirin in the treatment and prevention of cardiovascular disease. Am J Manag Care 2002:22 (Suppl);S691–S700.
Hennekens C, Peto R, Hutchison G, et al. An overview of the British and American aspirin studies. New Engl J Med 1988:318;923–924.
Squires S. More confusion over benefits of aspirin use. Los Angeles Times Nov 23, 1998:5.
Steinbrook R. Elderly warned about aspirin use medicine: findings in a USC study seem sure to stir controversy. Los Angeles Times Nov 18, 1989:32.
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media B.V
About this chapter
Cite this chapter
(2009). Research Results That Clashed – What's the Right Answer?. In: It's Great! Oops, No It Isn't. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8907-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-4020-8907-7_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-8906-0
Online ISBN: 978-1-4020-8907-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)